Trulieve Cannabis (OTC: TCNNF)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-14 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.070 | -0.010 | -0.0800 | ||||
REV | 320.520M | 320.300M | -220.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Trulieve Cannabis (OTCQX: TCNNF) through any online brokerage.
There are no as such competitors for Trulieve Cannabis.
The latest price target for Trulieve Cannabis (OTCQX: TCNNF) was reported by Cantor Fitzgerald on Thursday, August 11, 2022. The analyst firm set a price target for 54.00 expecting TCNNF to rise to within 12 months (a possible 301.79% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Trulieve Cannabis (OTCQX: TCNNF) is $13.44 last updated August 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for Trulieve Cannabis.
Trulieve Cannabis’s Q3 earnings are confirmed for Monday, November 14, 2022.
There is no upcoming split for Trulieve Cannabis.
Trulieve Cannabis is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.